Nathan Lawless is a highly experienced professional in computational biology and bioinformatics, currently serving as the Director of Research External Innovation for Europe at CSL since June 2023. Previously, Nathan held various significant roles at Boehringer Ingelheim from July 2017 to June 2023, including Interim Head of Computational Biology Germany and Head of External Innovation in Global Computational Biology & Digital Sciences. Key contributions involved leading a multi-disciplinary team focused on integrating omics data into drug discovery. Nathan's earlier experience includes a Senior Bioinformatician position at Eli Lilly and Company, where analytical solutions for neurodegenerative disorders were delivered, and a Postdoctoral Research Scientist role at The Pirbright Institute. Nathan earned a Ph.D. in Bioinformatics & Immunology from Trinity College Dublin, alongside a Master's in Immunology and Global Health from Maynooth University and a Bachelor's in Microbiology from University of Galway.
This person is not in any teams
This person is not in any offices